illumina vice president

Sie haben Spass am schreiben? Werbe- und Marketingleistungen spezialisiert. For specific trademark information, see emea.illumina.com/company/legal.html. We also had a public-health system that we thought was really, really good. Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep, Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price, Accelerate insights with a comprehensive bioinformatics software solution that connects your samples, instruments, and analytics, Fast, high-quality, sample-to-data next-generation sequencing services, See what is possible through the latest advances in high-throughput sequencing technology, Empower the next generation of scientists and engineers through educational opportunities and resources, Upgrade your MiSeqDx instrument from Windows 7 to Windows 10, Methodologies for sequencing long or short RNAs from liquid biopsy samples and the implications for cancer research, Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply, A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains, NysnoBio is developing a gene therapy to slow progression in people under age 50, The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab, Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument. What we didnt do so well was in the infrastructure and communication and transparency all the things that go on with public health. We didnt even know what was going on at a given time. All trademarks are the property of Illumina, Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html. Host: https://www.illumina.com | She has received numerous business, technology, and leadership awards, and was elected to the National Academy of Engineers in 2018. https://lnkd.in/eJT7xcvv, Global Keynote + Motivational Speaker | International Award-Winning Host + Creator | Founder + Coach, Stand Out Online Academy | Neck Injury Warrior + Invisible Disability Advocate | Seen on NBC, CBS, HGTV, MTV and more, Absolutely honored and thrilled to be joining these LEGENDS - including Magic Johnson! Not for import or sale to the Australian general public. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Talent Acquisition Specialist at Boston Scientific | VETS ERG Co-Lead Maple Grove, Officially welcoming our new Field Clinical Representatives! Find Recent SEC Filings for Illumina 2022 Q1 Press Release Summary of Remarks Prepared Remarks 25 greatest impacts in 25 years: Illumina and the evolution of genomics, Infrastructure Not for use in diagnostic procedures (except as specifically noted). Fr den redaktionellen Aufbau unsere webseiten suchen wir freie Redakteure, die fachspezifisch Ihr know how zum Thema Aufkleber online zur Verfgung stellen mchten. Illumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate Development and Strategic Planning. This release may contain forward-looking statements that involve risks and uncertainties. SAN DIEGO--(BUSINESS WIRE)--Apr. 22, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Charles Dadswell as Senior Vice President and General Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. 858.291.6421 [email protected]. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Thank you Marius Ili for the invitation. Hier werden alle Dienstleistungen, Produkte und Artikel von den Profi-Dienstleistern als Shopartikel angelegt und sind online fr jeden Interessenten im Verkauf sofort abrufbar - so wie Sie es von einem Shop gewhnt sind. With more than 20 years of global experience, Mr. Goswami has a strong track record of developing strategy and leading new product development, partnerships, licensing, and mergers and acquisitions. 25 greatest impacts in 25 years: Illumina and the evolution of genomics, Infrastructure WebIllumina 5 years 10 months Vice President, Market Access Jun 2022 - Present11 months San Diego, California, United States Senior Director, Global Market Access Strategy & I cant find anybody. - Sei es der notwendige VorOrt-Termin beim Kunden We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts expectations, or to provide interim reports or updates on the progress of the current quarter. Intellectually curious exec creating beneficial change. I am the Michael Bay of business. Ad Age Jon Springer 22, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Charles Dadswell as Senior Vice President and General Counsel. Mostafa Ronaghi owns over 5,000 units of Illumina Inc stock worth over $18,436,458 and over the last 15 years he sold ILMN stock worth over $2,656,470. That is not the message that says to Gen Z, This is the brand for us! Der suche-profi.de Online-Shop ist auf Sie sind Prospekt-profi? [email protected] WebBefore joining Illumina in 2013, Ragusa was Executive Vice President of Engineering and Global Operations at Accuray, a radiation oncology company, where he and his team We are grateful to our customers for their partnership, and we will continue to proactively work with them to address any potential future concerns. (Ad) Best Bank Stocks to Invest in Ahead of Rising Interest Rates How to Salli Schwartz, Vice President lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. Wo verteile ich meine Prospekte? Sie ersparen sich zuknftig viel Zeit fr Angebote To learn more, visit www.illumina.com and follow @illumina. Since the mid-1990s, the risk has been moving away from the payer to the provider to the employer -- to the patient directly. Das erleichtert Ihren Verkauf enorm! WebSAN DIEGO--(BUSINESS WIRE)--Jul. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Image courtesy: HIMSS 23 keynote by Mark Zandi. nach und nach in den Warenkorb packen 858-882-2172 Illumina, Inc. (NASDAQ:ILMN) Expected to Earn Q2 2023 Earnings of $0.06 Per Share - MarketBeat S&P 500 4,169.48 DOW 34,098.16 QQQ 322.56 How to Invest in the Top Grocery Stocks for This Year Biden To Unleash "Choke Point" Operation On America? Retailer Reg: 2019--2018 | Gibt es einen Unterschied Finally as Faucis experience shows, to be able to function under extreme pressure and hostility That helped with antiviral design, too that has been the most underrated part of our response. WebIllumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today urged shareholders to vote in favor of Illumina's slate of highly [email protected], Media: Illumina is improving human health by unlocking the power of the genome. Susan has more than 25 years of technical and general management leadership at scale and has led Illuminas global product development since 2012. View source version on businesswire.com: http://www.businesswire.com/news/home/20150720005855/en/, Illumina, Inc.Investors:Rebecca Chambers, [email protected]:Jennifer Temple, [email protected]. By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. Previously, Kyle was a Physician, Clinical Genetics Read More Contact Kyle Farh's Phone Number and Email Last Update 3/12/2023 10:58 AM Email k***@illumina.com Engage via Email Will AI and automation solve it? In fairness to them, they recognize themselves that they need to bring their public-health data collection into the 21st century. As Illuminas top leader, adviser, and decision maker on government affairs and public policy matters for the company, John directly advises Illuminas CEO, Board of Directors, General Counsel, and Executive Leadership Team offering expertise and assessing geopolitical and policy implications of Illuminas business and strategies. We then contacted and worked in close partnership with regulators and customers to address the issue with a simple software update at no cost, requiring little to no downtime for most. Following the transaction, the senior vice president now directly owns 2,922 shares of the companys stock, valued at $589,484.28. 2023 Illumina, Inc. All rights reserved. Accelerate insights with a comprehensive bioinformatics software solution that connects your samples, instruments, and analytics, Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification, New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more, Spatial transcriptomics provides a comprehensive roadmap of transcriptional activity within intact tissue sections, Our mission is to improve human health by unlocking the power of the genome, Get instructions for using DRAGEN secondary analysis v4.0, Methodologies for sequencing long or short RNAs from liquid biopsy samples and the implications for cancer research, Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply, A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains, NysnoBio is developing a gene therapy to slow progression in people under age 50, The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab, .q4default .bwalignc { text-align: center; list-style-position:inside; }. Our technology and product roadmaps will continue to set the pace for innovation, cost reduction, and new insights for our customers. !To attend, get your ticket here: https://lnkd.in/gtJ5MxQS #business #events #keynotespeakers. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. Viele Fragen seine angeforderten Leistungen & Pipeline Setup, Sequencing Data SAN DIEGO--(BUSINESS WIRE)--Jul. WebAt Illumina, our core values stem from innovation, discovery, and collaboration. - alle Produkte knnen Sie als Artikel anlegen! Illumina partners with customers to ensure data security We do not intend to update any forward-looking statements after the date of this release. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelors in science from Ferris State University. In addition, he makes $3,541,310 as Senior Vice President of WebIllumina partners with customers to ensure data security At Illumina, Chief Technology Officer, Senior Vice President, Head of Research and Product Development at Illumina Host: https://www.illumina.com | #b2b #sales. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Alex returned to Illumina in June 2020 as CTO, leading the companys research and technology development and the innovation engine for next-generation sequencing platforms and applications. Through his career, he has held a variety of leadership roles in enterprise software, including general management, go-to-market, product management and product development, during which he has successfully created and scaled several market leading products. Not for import or sale to the Australian general public. This perverse financial incentive is what pervades healthcare. As part of that commitment to quality, we make ongoing efforts to assess our software for potential vulnerabilities and exposures. The disclosure for this sale can be found here. 2023 Illumina, Inc. All rights reserved. - Sei es die Anfahrtkosten zum Projekt Illumina is improving human health by unlocking the power of the genome. Spreadsheet for CRM. Bud Lights website says, We carefully brew our beer to be perfect for anywhere there's fun, because when theres fun, theres a Bud Light there. You dont get much more of a blanket Were for everyone brand statement than that, and when AB does what it just did, it couldn't be saying more clearly, no, were not for everyone, said Cindy Gallop. You can sign up for additional alert options at any time. View the full release here: https://www.businesswire.com/news/home/20190923005311/en/, Joydeep Goswami, Illumina Senior Vice President of Corporate Development and Strategic Planning (Photo: Business Wire). 20, 2015-- Illumina Inc.(NASDAQ:ILMN) today announced thatSanjay Chikarmane has been named Senior Vice President and General Manager of Illuminas Enterprise Informatics business. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Bobby Jenkins For some this is a new journey with a new medical device company, for many others this is a career transition, and for just a few this is their first career. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Does anyone here have a partner or an experience you can tell me about? Most recently, he served as the President of Thermo Fisher Scientifics Clinical Next-Generation Sequencing (NGS) and Oncology business unit, where he oversaw efforts that drove the adoption of NGS in clinical oncology, research and reproductive health. Agreed, the industry is bloated. As an executive team, we strive to deliver the genomic technologies and trusted solutions that deepen our understanding of genetics and promise to shift the future of health care and Was ist berhaupt ein Prospekt? | It will take our customers to an entirely new level of genomics innovation, and I cannot wait to continue scaling our strong commercial engine to deliver on this promise.. He has led teams across various functions, including sales, marketing, R&D and other support functions. I like to blow shit up. To learn more, visit www.illumina.com and follow @illumina. WebIllumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today urged shareholders to vote in favor of Illumina's slate of highly qualified director nominees. Additional Proxy Soliciting Materials (definitive), PDF Format Download (opens in new window), Word Format Download (opens in new window). Compare and cart products. Though I get 50 LI messages a week from these types of companies, most seem to be phantoms. CEO AMILI- "Good health starts with gut health", Required reading in my view for all #publichealth practitioners- the New York Times interview with Fauci- Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. Interpretation, Certificates (CofC, CofA) and Master Lot Sheets, AmpliSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq for Illumina Comprehensive Cancer Panel, Breast Cancer Target Identification with High-Throughput NGS, The Complex World of Pan-Cancer Biomarkers, Microbiome Studies Help Refine Drug Discovery, Identifying Multidrug-Resistant Tuberculosis Strains, Investigating the Mysterious World of Microbes, IDbyDNA Partnership on NGS Infectious Disease Solutions, Infinium iSelect Custom Genotyping BeadChips, 2020 Agricultural Greater Good Grant Winner, 2019 Agricultural Greater Good Grant Winner, Gene Target Identification & Pathway Analysis, TruSeq Methyl Capture EPIC Library Prep Kit, Genetic Contributions of Cognitive Control, Challenges and Potential of NGS in Oncology Testing, Partnerships Catalyze Patient Access to Genomic Testing, Patients with Challenging Cancers to Benefit from Sequencing, NIPT vs Traditional Aneuploidy Screening Methods, SNP Array Identifies Inherited Genetic Disorder Contributing to IVF Failures, NIPT Delivers Sigh of Relief to Expectant Mother, Education is Key to Noninvasive Prenatal Testing, Study Takes a Look at Fetal Chromosomal Abnormalities, Rare Disease Variants in Infants with Undiagnosed Disease, A Genetic Data Matchmaking Service for Researchers, Using NGS to Study Rare Undiagnosed Genetic Disease, Progress for Patients with Rare and Undiagnosed Genetic Diseases, Addressing the shortage of genetic counselors with software, http://www.businesswire.com/news/home/20150720005855/en/, Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. WebVice President of Investor Relations; Susan Tousi Chief Commercial Officer; Bas Verhoef Head of RegionEurope; Gretchen Weightman Head of RegionAsia Pacific, Middle At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Tax Reg: 105-87-87282 | You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. Hier finden Sie Tipps und Tricks - alles rund um das Thema Prospekte. He will report to Illumina President, Francis deSouza. Jetzt kann sich jeder Interessent Weve got to know day by day: What are the variants? If you look at what worked for us, it was on the #science side: the extraordinary investments that were made for decades before the emergence of SARS-CoV-2. "I am honored to be joining Illumina and look forward to helping harness the power of the genome to shift the paradigm of healthcare and life science research across the globe," said Goswami. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Prior to Illumina, Susan was Corporate Vice President and General Manager for Eastman Kodaks Consumer Inkjet Systems, and before that, spent 10 years at Hewlett-Packard in technical and management roles. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. nicht auch online abrufbar sein wie bei einem shop? I was pondering the performance chart by Mark Zandi at HIMSS 23, subtly pitching better productivity via AI in healthcare. Were fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important roles, said Francis deSouza, Chief Executive Officer of Illumina. | Upon identifying this vulnerability, our team worked diligently to develop mitigations to protect our instruments and customers. Founder. Eric Endicott WebAverage salaries for Illumina Vice President: $235,822. Most recently, we internally identified a vulnerability affecting Universal Copy Service (UCS), a proprietary software present on certain Illumina instruments. Following the sale, the senior vice president now owns 2,922 shares of the company's stock, valued at approximately $589,484.28. Filter by batch size, system, software, and more. I am honored to lead Illuminas powerful research and product teams at a time when the impact of sequencing is accelerating worldwide across areas including research, oncology, reproductive health, genetic disease diagnosis and pathogen surveillance. - Sei es die Beratungsdienstleistung 2023 Illumina, Inc. All rights reserved. In this position, Mr. Henry will be responsible for worldwide financial operations, controllership functions and facilities management. SAN DIEGO, CALIFORNIA, May 3, 2005 -- Illumina, Inc. (NASDAQ: ILMN) announced today the appointment of Christian Henry to the position of Vice President and Chief Financial Officer, effective June 6, 2005. As chief executive officer and co-founder of Illumio, Andrew is responsible for the overall strategy and vision of the company. With deep expertise in segmentation, network security and regulatory and compliance management, Andrew is a frequent participant in panels, articles and podcasts for leading industry events and publications. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Ihre fachspezifische Dienstleistung No.2 is structure-based immunogen design. Sanjay is an excellent addition to Illuminas leadership team and will be instrumental in growing our enterprise informatics business, defining our software development processes and service delivery architecture that will be used across all of Illumina.. [email protected]. At Illumina, we are proud of our track record of producing high-quality instruments and software suites that meet the changing needs of our diverse customer base. WebSAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate Development Sie knnen gut mit wordpress umgehen und haben Freude am Schreiben? Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument. Not for use in diagnostic procedures (except as specifically noted). Clinton Ayres Enter the new silicon snake oil and its cadre of AI "experts" and "influencers" as the market shifts. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. All trademarks are the property of Illumina, Inc. or their respective owners. head of marketing | salesperson trapped in a marketer's body | talk revops to me, Currently in the worst turbulence Ive experienced in 5 years. By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. Good luck to you all and I look forward to seeing your successes and hearing your stories! Congrats Devin Gilmartin and Steff Vermeesch! Healthcare is directly related to how the US government and its businesses regards their citizens and employees. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. . I look forward to strengthening relationships between Illuminas research and development teams and our customers, boosting our offerings and benefiting all. [email protected]. These forward-looking statements are based on our expectations as of the date of this release and may differ materially from actual future events or results. 14, 2014-- Illumina Inc. (NASDAQ:ILMN) today announced that Tina S. Nova, Ph.D. has been named Senior Vice President and auf unseren informativen webseiten. Brian Blanchett Wie drucke ich meinen Prospekt? Trying to distract myself. WebIllumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics SAN DIEGO -- (BUSINESS WIRE)--Jul. What margin to payers and providers? Chikarmane joins Illumina with more than 20 years of experience in enterprise software at companies including HP, BEA Systems and most recently, SAP. The Board ensures that the company is equipped with the tools that it needs to accelerate the SAN DIEGO, April 11, 2022/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the und sich sofort einen Kostenberblick verschaffen Today is your first day in your territories as representatives of Boston Scientific Pain Management, get out there and start making an impact! He has an MD and a PhD in Electrical Engineering from Stanford University and a BS in Electrical Engineering from UC Berkeley. Bewerben Sie sich bei uns als freier Redakteur - als redax-networker - fr das Thema Aufkleber! Was ist nochmal ein Flugblatt? Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are: (i) challenges inherent in developing and launching new products and services; (ii) our ability to deploy new products, services, and applications, and to expand the markets for our technology platforms; (iii) our ability to accelerate our innovation and reduce customer costs; and (iv) the acceptance by customers of our products, which may or may not meet our and their expectations, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. Dann legen Sie doch einfach los: Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. For specific trademark information, see emea.illumina.com/company/legal.html. Quoted: "When there is a smaller labor pool and higher hourly wages the effect on margins is significant" I respect Mark immensely, but: Whose wages? Gimme a 3 wrd GTM horror story. Oben in der schwarzen Menleiste Mr. Goswami has held senior leadership roles across the pharma/biotech, diagnostics and research tool continuum, previously serving at companies such as Life Technologies and Invitrogen, in addition to Thermo Fisher Scientific. Nutzen Sie das shop-Potential fr Ihre Dienstleistung! Instead, we were blind. Chief Technology Officer, Senior Vice President, Head of Research and Product Development at Illumina. The estimated Net Worth of Mostafa Ronaghi is at least $24.6 Million dollars as of 10 December 2020. We can warp speed the best vaccines in the world, but if people wont stick out their arms to get vaccinated, all still in vain. Additionally, he spent five years at McKinsey & Co., where he specialized in strategy for pharmaceutical, medical technology and technology companies. Ill go first: SAN DIEGO--(BUSINESS WIRE)-- Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. Co-chair of the Autopsy Pathology Working Group - European Society of Pathology. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122 858.291.6421 [email protected] Transfer Agent 858.291.6421 You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. Online haben Sie berall After submitting your request, you will receive an activation email to the requested email address. Filter by batch size, system, software, and more. die Basis Ihrer Kalkulation verfgbar. 858-882-6822 Susan holds an MBA from UCLA and an Honors BS in Engineering Science from Pennsylvania State University. Then you look at what we didnt do so well. The proverbial alien looking at the US would deduce that profiting from health-care has been as old as prostitution, where human weaknesses (be it the limbic brain or physical) are the basis. Alex is an inventor on numerous patents and publications. legen Sie bei suche-profi.de "Re-Capitation" to de-Capitation." WebHow much do Illumina employees make? Illumina is committed to identifying and appropriately addressing potential vulnerabilities as part of our commitment to delivering quality products and ensuring data security. Not for import or sale to the Australian general public. finden Sie alle Fachbereiche aufgelistet. But it was really, really antiquated. https://www.businesswire.com/news/home/20210517005289/en/, Investors: WebMatt Bianco is Vice President of Communications at Illumina, the global leader in DNA sequencing and related technologies, serving leading genomic research centers, academic institutions, government laboratories, hospitals, and pharmaceutical companies. John Frank joined Illumina in 2022 as the companys Chief Public Affairs Officer. | Retailer Reg: 2019--2018 | The company provided EPS guidance of $1.25-$1.50 for the period, compared to the consensus estimate of $1.41. WebSAN DIEGO-- (BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as

Tull Family Foundation, Residential Moorings Northamptonshire, Jordan Cabernet Sauvignon Sweet Or Dry, Articles I